Surgical endoscopy · 2025
Concomitant laparoscopic cholecystectomy with bariatric surgery: current insights from the 2015-2021 MBSAQIP database.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rouhi Armaun D, Leon Sebastian, Rosen Claire B, Ginzberg Sara P, Perez Juan E, Vasisht Shubha, Tewksbury Colleen M, Altieri Maria S, Gershuni Victoria M, Williams Noel N, Dumon Kristoffel R
Аннотация
BACKGROUND: Obesity and cholelithiasis frequently coexist, leading to the consideration of combining bariatric surgery with laparoscopic cholecystectomy (LC) to address both conditions in a single procedure. This study analyzed short-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) with concomitant LC using MBSAQIP registry data.
METHODS: Adults undergoing primary SG or RYGB, with and without concomitant LC (SG-LC and SG-only or RYGB-LC and RYGB-only, respectively), were analyzed from the 2015-2021 MBSAQIP database. Differences in baseline characteristics by LC status for each bariatric procedure were adjusted using entropy balancing. Multivariable weighted logistic and linear regressions were developed to evaluate the independent association between concomitant LC and 30-day outcomes of interest.
RESULTS: Of 852,640 patients who underwent SG, 8705 (1.0%) received concomitant LC, while 5343 (1.6%) of 336,838 RYGB patients underwent concomitant LC. Compared to SG-only, SG-LC patients had significantly higher 30-day rates of superficial SSI (0.6% vs. 0.3%, p < 0.001), unplanned intubation (0.3% vs 0.1%, p = 0.001), and pneumonia (0.3% vs. 0.1%, p = 0.042). RYGB-LC patients experienced higher rates of septic shock (0.3% vs. 0.2%, p = 0.040), reoperation (3.5% vs. 2.7%, p = 0.009), and unplanned intubation (0.6% vs. 0.3%, p = 0.007) than RYGB-only. These were rare events with little absolute difference between LC and non-LC cohorts. Adjusted multivariate analyses confirmed increased odds of unplanned intubation (SG-LC: AOR 2.01, 95% CI 1.03-3.01; RYGB-LC: AOR 2.27, 95% CI 1.17-4.40) and superficial SSI (SG-LC: AOR 2.01, 95% CI 1.35-3.01; RYGB-LC: AOR 1.41, 95% CI 1.01-1.98) in both LC cohorts, as well as septic shock (AOR 2.83, 95% CI 1.46-5.48) among RYGB-LC. Neither SG-LC nor RYGB-LC demonstrated an association with perioperative mortality, reoperation, leakage, or gastrointestinal bleeding.
CONCLUSIONS: In this 7-year registry study of over 1 million patients, bariatric surgery with concomitant LC demonstrated a favorable safety profile with no association with perioperative mortality after risk adjustment.
METHODS: Adults undergoing primary SG or RYGB, with and without concomitant LC (SG-LC and SG-only or RYGB-LC and RYGB-only, respectively), were analyzed from the 2015-2021 MBSAQIP database. Differences in baseline characteristics by LC status for each bariatric procedure were adjusted using entropy balancing. Multivariable weighted logistic and linear regressions were developed to evaluate the independent association between concomitant LC and 30-day outcomes of interest.
RESULTS: Of 852,640 patients who underwent SG, 8705 (1.0%) received concomitant LC, while 5343 (1.6%) of 336,838 RYGB patients underwent concomitant LC. Compared to SG-only, SG-LC patients had significantly higher 30-day rates of superficial SSI (0.6% vs. 0.3%, p < 0.001), unplanned intubation (0.3% vs 0.1%, p = 0.001), and pneumonia (0.3% vs. 0.1%, p = 0.042). RYGB-LC patients experienced higher rates of septic shock (0.3% vs. 0.2%, p = 0.040), reoperation (3.5% vs. 2.7%, p = 0.009), and unplanned intubation (0.6% vs. 0.3%, p = 0.007) than RYGB-only. These were rare events with little absolute difference between LC and non-LC cohorts. Adjusted multivariate analyses confirmed increased odds of unplanned intubation (SG-LC: AOR 2.01, 95% CI 1.03-3.01; RYGB-LC: AOR 2.27, 95% CI 1.17-4.40) and superficial SSI (SG-LC: AOR 2.01, 95% CI 1.35-3.01; RYGB-LC: AOR 1.41, 95% CI 1.01-1.98) in both LC cohorts, as well as septic shock (AOR 2.83, 95% CI 1.46-5.48) among RYGB-LC. Neither SG-LC nor RYGB-LC demonstrated an association with perioperative mortality, reoperation, leakage, or gastrointestinal bleeding.
CONCLUSIONS: In this 7-year registry study of over 1 million patients, bariatric surgery with concomitant LC demonstrated a favorable safety profile with no association with perioperative mortality after risk adjustment.